Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2014-003671-30-ES
EUCTR2014-003671-30-ES
Active, not recruiting
Phase 1

Therapeutic effect of propranolol in a series of patients with von Hippel-Lindau disease and retinal hemangioblastomas in short, medium and long term treatment.

ALIANZA ESPAÑOLA DE FAMILIAS DE VON HIPPEL-LINDA0 sitesSeptember 22, 2014
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsSUMIAL 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
ALIANZA ESPAÑOLA DE FAMILIAS DE VON HIPPEL-LINDA
Status
Active, not recruiting
Last Updated
9 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 22, 2014
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
ALIANZA ESPAÑOLA DE FAMILIAS DE VON HIPPEL-LINDA

Eligibility Criteria

Inclusion Criteria

  • •PATIENTS DIAGNOSED OF VON HIPPEL\-LINDAU DISEASE AND RETINAL HEMANGIOBLASTOMAS, THAT IN ADDITION:
  • •\- AT LEAST ONE PAPILLARY OR JUXTAPAPILLARY HB, OR
  • •\- PERIPHERICAL HB, WHO HAD REJECTED ANOTHER TREATMENTS
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range: 1
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 9
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •CONTRAINDICATIONS TO TAKE PROPRANOLOL

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
PROPRANOLOL IN BURNT ADULT PATIENTSBURNT-INDUCED SINUSAL TACHYCARDIATherapeutic area: Diseases [C] - Injuries, poisonings, and occupational diseases [C21]
EUCTR2014-001380-13-ESAbelardo Garcia De Lorenzo / Teresa Nuñez-Villaveiran
Recruiting
Phase 3
The role of propranolol with L-carnitine in the prophylactic treatment of cyclic vomiting syndrome
IRCT20120716010297N9Esfahan University of Medical Sciences104
Active, not recruiting
Not Applicable
Safety and efficacy of treatment with propranolol in newborns suffering from rethinopathy of the preterm: a pilot study - Propranolol and ROPRetinopathy of the pretermMedDRA version: 9.1Level: HLGTClassification code 10047060
EUCTR2010-018737-21-ITAZIENDA OSPEDALIERA MEYER
Completed
Not Applicable
Clinical study of oral propranolol treatment for pediatric hemangioma and lymphangiomapediatric hemangioma and lymphangioma
JPRN-UMIN000004453Gifu University Graduate School of Medicine50
Recruiting
Phase 3
Investigating the efficacy of oral propranolol in prevention of severe Retinopathy of Prematurity
IRCT20101018004961N12Kermanshah University of Medical Sciences50